CEO, AVID BIOSERVICES
WHY: Leads Tustin-based contract drug manufacturer (Nasdaq: CDMO). Company shares increased nearly threefold since named CEO in June 2020.
IN THE NEWS: Opened $75M, 53K-square-foot Costa Mesa facility in eight months, designed and built by construction firm CRB. Second phase will be operational in mid-calendar year 2023.
QUOTABLE: “Considering the challenges of the current supply chain environment, it has been nothing short of remarkable for Avid and CRB to be opening the doors of Avid’s new viral vector process development labs here in June.”
